சிஇவிஏ விலங்கு ஆரோக்கியம் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிஇவிஏ விலங்கு ஆரோக்கியம் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிஇவிஏ விலங்கு ஆரோக்கியம் இன்க் Today - Breaking & Trending Today

SeQuent announced launch of Citramox® LA in EU


SeQuent announced launch of Citramox® LA in EU
Posted On:
2020-12-10 02:24:52
(Time Zone: Arizona, USA)
SeQuent Scientific Limited (SeQuent), announced launch of Citramox® LA 150 mg/ml Suspension Injection for Cattle and Pigs in 10 European countries, including the key markets of Western Europe. The product has recently received approval through its Spanish subsidiary Laboratorios Karizoo, S.A., and will be the first Long-Acting injectable to be offered by SeQuent in Europe.
This new approval for SeQuent builds on the recent approvals of Tulazzin® (Tulathromycin) and Halofusol® (Halofuginone) in Europe. All these approvals have been received within 12 months of filing, which reflects on SeQuent s growing strengths in introducing new products for the regulated markets. ....

Laboratorios Karizoo , Ceva Animal Health Inc , Sequent Scientific Limited , Quent Scientific Limited , Suspension Injection , Amoxicillin Long Acting , சிஇவிஏ விலங்கு ஆரோக்கியம் இன்க் , தொடர்ச்சி அறிவியல் வரையறுக்கப்பட்டவை , க்வெஂட் அறிவியல் வரையறுக்கப்பட்டவை , இடைநீக்கம் ஊசி ,

Sequent Scientific gains after launching Citramox LA in Europe


Sequent Scientific rose 2.09% to Rs 173.45 after the company announced the launch of Citramox LA 150 mg/ml suspension injection for cattle and pigs in 10 European countries, including the key markets of Western Europe.
The product has recently received approval through its Spanish subsidiary Laboratorios Karizoo, S.A., and will be the first Long-Acting injectable to be offered by the company in Europe. This new approval for SeQuent Scientific builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe. All these approvals have been received within 12 months of filing.
Citramox is the first generic version of Vetrimoxin LA (Innovator: Ceva Animal Health Inc) to be approved and launched in Europe, which is an effective antibiotic indicated for the treatment of respiratory infections caused by Mannheimia haemolytica and Pasteurella multocida susceptible to amoxicillin in cattle and pigs. ....

Laboratorios Karizoo , Tulazzin Tulathromycin , Halofusol Halofuginone , Ceva Animal Health Inc , Sequent Scientific , Amoxicillin Long Acting , Active Pharmaceutical Ingredients , Capital Market , சிஇவிஏ விலங்கு ஆரோக்கியம் இன்க் , தொடர்ச்சி அறிவியல் , செயலில் மருந்து பொருட்கள் , மூலதனம் சந்தை ,